Abiopharma

New Form 6-K - GENMAB A/S Filed: 2025-08-07 AccNo: 0001434265-25-000061 Size: 131 KB

Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)

New Form SCHEDULE 13G/A - Viatris Inc Filed: 2025-08-07 AccNo: 0001036325-25-000015 Size: 6 KB

Smith+Nephew PLC Notification

New Form SCHEDULE 13G/A - SOLENO THERAPEUTICS INC Filed: 2025-08-07 AccNo: 0000315066-25-002184 Size: 11 KB

New Form SCHEDULE 13G/A - CYTOKINETICS INC Filed: 2025-08-07 AccNo: 0000315066-25-002178 Size: 11 KB

New Form SCHEDULE 13G/A - CARGO Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0000315066-25-002179 Size: 10 KB

New Form SCHEDULE 13G/A - Disc Medicine, Inc. Filed: 2025-08-07 AccNo: 0000315066-25-002182 Size: 11 KB

New Form SCHEDULE 13G/A - GLAUKOS Corp Filed: 2025-08-07 AccNo: 0000315066-25-002181 Size: 11 KB

The latest from NRC Health | Can we embrace AI without losing humanity, the latest CAHPS Insider, and so much more!

New Form SCHEDULE 13G/A - 10x Genomics, Inc. Filed: 2025-08-07 AccNo: 0000315066-25-002176 Size: 14 KB

SeaStar Medical - SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

New Form SCHEDULE 13G/A - HARVARD BIOSCIENCE INC Filed: 2025-08-07 AccNo: 0001019432-25-000022 Size: 7 KB

New Form 10-Q - ELI LILLY & Co Filed: 2025-08-07 AccNo: 0000059478-25-000204 Size: 10 MB

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025